arrow
L

Lisa K. Hicks

University of Toronto
H指数:31
被引数:4,449

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immunogenicity and Safety of a Third and Subsequent COVID-19 Vaccine Doses in Patients with Plasma Cell Dyscrasias

第三剂及后续剂次的COVID-19疫苗在浆细胞疾病患者中的免疫原性和安全性

2026-02-170
OAAI
Tenofovir alafenamide for prevention of HBV reactivation in HBsAg-negative, anti–HBc-positive patients undergoing rituximab-based chemotherapy: A multicenter randomized controlled trial

替诺福韦艾拉酚胺用于预防HBsAg阴性、抗-HBc阳性患者接受利妥昔单抗为基础化疗时HBV再激活:一项多中心随机对照试验

2025-12-030
OAAI
Immunogenicity and safety of third, fourth and subsequent COVID-19 vaccine doses in recipients of hematopoietic cell transplantation and cellular therapy

造血细胞移植和细胞治疗受者接种第三、第四及后续COVID-19疫苗剂量的免疫原性和安全性

2025-11-080
PRE
Incremental immunogenicity of multiple doses of SARS-CoV-2 vaccination in patients with haematological malignancies

多剂量SARS-CoV-2疫苗接种在血液恶性肿瘤患者中的增量免疫原性

2025-07-300
OAAI
Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial
2021-12-0691
OAAI